Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection (PROCEED-CRC)

NCT06620627 is registered in ClinicalTrials.gov with Natera, Inc. as lead sponsor.

NCT NCT06620627
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06620627 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection (PROCEED-CRC)
Lead sponsor
Natera, Inc.
Phase
Observational
Overall status
Recruiting
Start date
January 26, 2024
Completion date
October 31, 2025
Enrollment
5,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer screening